GE Healthcare Leverages AI to Enhance Global Patient Care
Global, Friday, 3 January 2025.
GE Healthcare is integrating AI to improve diagnostics and patient management, aiming for over 200 AI-enabled device authorizations by 2028, enhancing healthcare delivery worldwide.
Leading the AI Healthcare Revolution
GE Healthcare has established itself as a frontrunner in AI-enabled healthcare solutions, maintaining its position at the top of the FDA’s list for AI-enabled device authorizations for three consecutive years with over 80 authorizations [1]. Under the leadership of Global Chief Science and Technology Officer Dr. Taha Kass-Hout, the company is aggressively expanding its AI capabilities, targeting to triple its cloud-enabled product offerings and achieve more than 200 AI-enabled device authorizations by 2028 [1].
Transformative Impact on Cancer Care
One of GE Healthcare’s groundbreaking initiatives is the Health Companion project, which revolutionizes cancer care delivery through AI. This innovative system employs multiple AI agents to simulate a multidisciplinary cancer care team, significantly reducing the time required for tumor board assembly from weeks to potentially days [1]. The company’s commitment to oncology care is further demonstrated through CareIntellect for Oncology, scheduled for wide U.S. release in 2025, which promises to reduce patient history review time from hours to minutes [1].
AI-Guided Ultrasound Innovation
In a significant development for global healthcare access, GE Healthcare has partnered with the Bill & Melinda Gates Foundation to expand AI-enabled portable ultrasound technology to underserved regions [2]. The technology provides real-time feedback during ultrasound scans, utilizing deep learning algorithms to assist users in capturing high-quality images. According to Radhika Madhavan, Global Product Manager for AI Solutions at GE Healthcare, ‘One of the biggest barriers to using ultrasound is having the right skills. But with AI-driven scan guidance…the user receives real-time, step-by-step feedback to maneuver the ultrasound probe, almost like GPS’ [2].
Future Outlook and Industry Impact
Looking ahead to 2025, industry experts predict significant advances in multimodal AI and diagnostic imaging capabilities [5]. Roland Rott, president and CEO of imaging at GE Healthcare, emphasizes that ‘AI is driving meaningful advances in diagnostic imaging, allowing radiologists to detect subtle abnormalities that might be impossible to discern with the human eye’ [5]. The company’s focus remains on responsible AI development, with Dr. Kass-Hout stating, ‘AI has tremendous potential to help. However, for it to be safe and effective, it must be developed and practiced responsibly’ [1].